Klamroth, R. Et Al. 2025. Perioperative Management With Efanesoctocog Alfa in Patients With Haemophilia A in the Phase 3 XTEND-1 and XTEND-Kids Studies. Haemophilia , vol.31, no.3 , 391-400.

Klamroth, R., von Drygalski, A., Hermans, C., Park, Y., Chan, A. K. C., Kupesiz, A., ... Alvarez-Román, M. T.(2025). Perioperative Management With Efanesoctocog Alfa in Patients With Haemophilia A in the Phase 3 XTEND-1 and XTEND-Kids Studies. Haemophilia , vol.31, no.3, 391-400.

Klamroth, Robert Et Al. "Perioperative Management With Efanesoctocog Alfa in Patients With Haemophilia A in the Phase 3 XTEND-1 and XTEND-Kids Studies," Haemophilia , vol.31, no.3, 391-400, 2025

Klamroth, Robert Et Al. "Perioperative Management With Efanesoctocog Alfa in Patients With Haemophilia A in the Phase 3 XTEND-1 and XTEND-Kids Studies." Haemophilia , vol.31, no.3, pp.391-400, 2025

Klamroth, R. Et Al. (2025) . "Perioperative Management With Efanesoctocog Alfa in Patients With Haemophilia A in the Phase 3 XTEND-1 and XTEND-Kids Studies." Haemophilia , vol.31, no.3, pp.391-400.

@article{article, author={Robert Klamroth Et Al. }, title={Perioperative Management With Efanesoctocog Alfa in Patients With Haemophilia A in the Phase 3 XTEND-1 and XTEND-Kids Studies}, journal={Haemophilia}, year=2025, pages={391-400} }